Showing 2,321 - 2,340 results of 113,842 for search '(( 50 ((mean decrease) OR (a decrease)) ) OR ( 5 ((mean decrease) OR (a decrease)) ))', query time: 1.20s Refine Results
  1. 2321

    SmedCB shows a transient spike of protease activity following digestion and amputation, while chemical inhibition of both cathepsin B and L leads to a significant decrease in regen... by Louise S. Goupil (2922159)

    Published 2016
    “…<b>(C)</b> Worms treated with SmedCB dsRNA did not show any significant defects in regeneration compared to untreated controls, but treatment with K11777 <b>(D)</b> showed a highly significant decrease in growth compared to vehicle worms. …”
  2. 2322
  3. 2323
  4. 2324
  5. 2325
  6. 2326

    Pretreatment with terazosin (0.5, 1 mg/kg) reversed the decrease in EEG amplitude produced by modafinil (90 mg/kg, i.p.). by Chang-Rui Chen (467755)

    Published 2013
    “…The increase in EEG amplitude may be interpreted as synchronization and a decrease in EEG can be interpreted as a desynchronization. …”
  7. 2327
  8. 2328
  9. 2329

    The wound healing microenvironment restored GJIC but did not directly decrease tumor cells. by Linxin Liu (829738)

    Published 2015
    “…(B and C) The combination of three compounds led to angiogenesis and optimal fibroblast proliferation but did not directly decrease A549 cancer cells. The results are presented as mean±SE (n = 5/group) **<i>p</i> < 0.01 <i>vs</i> control group.…”
  10. 2330
  11. 2331
  12. 2332
  13. 2333
  14. 2334
  15. 2335

    Sarcopenia as an Independent Risk Factor for Decreased BMD in COPD Patients: Korean National Health and Nutrition Examination Surveys IV and V (2008-2011) by Dong-Won Lee (2208223)

    Published 2016
    “…<div><p>Background</p><p>A decrease in bone mineral density (BMD) is a systemic consequence of chronic obstructive pulmonary disease (COPD). …”
  16. 2336

    Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%. by Joseph Kamgno (81039)

    Published 2016
    “…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”
  17. 2337
  18. 2338
  19. 2339

    PLD inhibitors decrease PLD2 expression in foci of lungs following xenotransplantation. by Karen M. Henkels (3350273)

    Published 2016
    “…<p>(<b>A</b>) Primary tumor volume from xenotransplanted mice in the presence or absence (“control” = vehicle only) of PLD inhibitors delivered by Alzet pumps, as in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0166553#pone.0166553.g001" target="_blank">Fig 1</a> legend. …”
  20. 2340